Informationen:
Fehler:
ID
28922
Beschreibung
Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive Disorder; ODM derived from: https://clinicaltrials.gov/show/NCT01145313
Link
https://clinicaltrials.gov/show/NCT01145313
Stichworte
Versionen (1)
- 16.02.18 16.02.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
16. Februar 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Depressive Disorder, Major NCT01145313
Eligibility Depressive Disorder, Major NCT01145313
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Depressive Disorder, Major NCT01145313
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Criteria Fulfill
Item
patients who meet the following criteria will be included in the study:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,2])
Age
Item
aged 18 to 64 years
boolean
C0001779 (UMLS CUI [1])
Major Depressive Disorder
Item
diagnosis of major depressive disorder during the study timeframe (icd 9 codes 296.2, 296.3, 311)
boolean
C1269683 (UMLS CUI [1])
Antidepressive Agents
Item
evidence of at least 6 consecutive claims for traditional antidepressant therapy with a 30 day supply or at least 2 claims with a 90 day supply (consecutive defined as ≤15 days gap)
boolean
C0003289 (UMLS CUI [1])
Enrollment Continuous
Item
must be continually enrolled during the study timeframe and have both medical and pharmacy benefits
boolean
C1516879 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
C0549178 (UMLS CUI [1,2])
Atypical antipsychotic
Item
evidence of at least 4 consecutive claims for an atypical antipsychotic prescription with a 30 day supply or 2 claims with a 90 day supply (consecutive defined as ≤15 days gap)
boolean
C1276996 (UMLS CUI [1])
Antidepressive Agents prior to Atypical antipsychotic
Item
evidence of antidepressant therapy for at least 60 consecutive days prior to the initiation of atypical antipsychotic
boolean
C0003289 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
C1276996 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,2])
C1276996 (UMLS CUI [1,3])
Antidepressive Agents | Atypical antipsychotic Additional
Item
after at least a 60 day trial of traditional antidepressant medications, patient augments with an atypical antipsychotic medication for at least 4 months.
boolean
C0003289 (UMLS CUI [1])
C1276996 (UMLS CUI [2,1])
C1524062 (UMLS CUI [2,2])
C1276996 (UMLS CUI [2,1])
C1524062 (UMLS CUI [2,2])
Criteria Fulfill
Item
patients are excluded if they:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,2])
Schizophrenia | Schizoaffective Disorder | Bipolar Disorder
Item
have any claims for a diagnosis of schizophrenia, schizoaffective or bipolar disorder during the study period
boolean
C0036341 (UMLS CUI [1])
C0036337 (UMLS CUI [2])
C0005586 (UMLS CUI [3])
C0036337 (UMLS CUI [2])
C0005586 (UMLS CUI [3])
Electroconvulsive Therapy
Item
have electroconvulsive therapy (ect) during the study period
boolean
C0013806 (UMLS CUI [1])
Mood Stabilizer | Thyroxine | Triiodothyronine | Buspirone | Stimulant
Item
new augmentation with mood stabilizers, l-thyroxine (t4), l-thyronine (t3), buspirone, stimulant, or others during the post-period (table 1)
boolean
C2917435 (UMLS CUI [1])
C0040165 (UMLS CUI [2])
C0041014 (UMLS CUI [3])
C0006462 (UMLS CUI [4])
C0304402 (UMLS CUI [5])
C0040165 (UMLS CUI [2])
C0041014 (UMLS CUI [3])
C0006462 (UMLS CUI [4])
C0304402 (UMLS CUI [5])
Pregnancy
Item
are pregnant during the study period
boolean
C0032961 (UMLS CUI [1])
Patients Medicare | Patients Medicaid
Item
patients with medicare or medicaid
boolean
C0030705 (UMLS CUI [1,1])
C0018717 (UMLS CUI [1,2])
C0030705 (UMLS CUI [2,1])
C0025071 (UMLS CUI [2,2])
C0018717 (UMLS CUI [1,2])
C0030705 (UMLS CUI [2,1])
C0025071 (UMLS CUI [2,2])